Abstract

IntroductionA new Influenza A virus H1N1 appeared in March-April 2009, and thousands of cases are being reported worldwide. In the initial months, several imported cases were reported in many European countries, while some countries reported local chains of transmission. We describe the first cluster of in-country transmission of the new Influenza A H1N1 which occurred in Italy, involving 3 patients.Case presentationPatient 1, a 11-year-old male child developed fever, cough, and general malaise 4 days after returning from a travel to Mexico. Some days later, the 69-year-old grandfather (patient 2), who did not travel to Mexico, and the 33-month-old brother (patient 3) of patient 1 developed mild influenza symptoms. PCR tests resulted positive for Influenza A, and sequence analysis confirmed infection with the Influenza A (H1N1) strain for all three patients. Some problems were experienced in the administration of chemoprophylaxis and therapy in the patient 3. The chemoprophylaxis policies in other family members are described, too.ConclusionSome interesting facts emerge from the analysis of this cluster. The transmission of Influenza A H1N1 virus seems to be dependent on strict contacts. Patient 2 and patient 3 did not take the chemoprophylaxis properly. The problems in the administration of chemoprophylaxis and therapy to patient 3 suggest that in infants specific individual-based strategies for assuring the correct administration are advisable.

Highlights

  • A new Influenza A virus H1N1 appeared in March-April 2009, and thousands of cases are being reported worldwide

  • A new Influenza A H1N1 virus of swine origin appeared in March-April 2009, and because of its capability to be directly transmitted from human to human, thousands of cases are being reported worldwide

  • Sustained autochthonous transmission firstly appeared in Spain and United Kingdom [2], while presently local chains of transmission are ongoing in most European countries

Read more

Summary

Conclusion

This report briefly describe the first cluster of in-country transmission of the new Influenza A H1N1 which occurred in Italy. At the beginning of the pandemic, when these patients were observed, the treatment with oseltamivir (75-mg capsule twice per day for 5 days for adults, weight-based for children) or zanamivir (two 5-mg inhalations -10 mg total - twice per day for 5 days for adults and children older than 7-year-old) was usually administered to all patients. For this reason, in the described cluster therapy has been given to those patients presenting with mild symptoms, as patients 2 and 3. Similar clinical pictures are reported in the vast majority of other cases in the world

Background
CIDRAP
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.